Skip to main navigation Skip to search Skip to main content

Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands

  • Bart Slob*
  • , Tanja Fens
  • , Maaike Weersma
  • , Maarten Postma
  • , Cornelis Boersma
  • , Lisa de Jong
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases